H. G. Prentice

10.4k citations
178 papers · 7.7k · h-index 51

Impact in

  • Hematology top 0.1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 1%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

  • Hematology 111
    • Hematopoietic Stem Cell Transplantation 87
    • Acute Myeloid Leukemia Research 33
    • Chronic Myeloid Leukemia Treatments 13
  • Immunology 68
    • Immune Cell Function and Interaction 36
    • T-cell and B-cell Immunology 32
    • Immunotherapy and Immune Responses 22
Co-authors
A. V. Hoffbrand (32 shared papers)Malcolm K. Brenner (27 shared papers)George Janossy (11 shared papers)Hilary Blacklock (12 shared papers)J. Z. Wimperis (14 shared papers)M. J. M. L. Gilmore (9 shared papers)C Kibbler (2 shared papers)Mark W. Lowdell (6 shared papers)
Journals
Blood (31 papers)British Journal of Haematology (26 papers)Bone Marrow Transplantation (10 papers)The Lancet (9 papers)Journal of Medical Virology (5 papers)
Partner nations
United KingdomUnited StatesItaly

In The Last Decade

H. G. Prentice

176 papers receiving 7.2k citations

Peers

H. G. Prentice
Comparison fields: 5 of 119
  • Hematology 3.9k
  • Immunology 2.3k
  • Genetics 872
  • Transplantation 154
  • Infectious Diseases 1.1k
Replace Robert C. Hackman with:
Robert C. Hackman United States
George E. Sale United States
Jan Storek Canada
Rodrigo Martino Spain
Richard J. O’Reilly United States
Liisa Volin Finland
Montserrat Rovira Spain
Rafael F. Duarte Spain
Jan J. Cornelissen Netherlands
Hisashi Sakamaki Japan
H. G. Prentice relative to Robert C. Hackman United States Robert C. Hackman's profile →
Citations per field
00.5×1.5×
Robert C. Hackman · 1×
Citations per year

Countries citing papers authored by H. G. Prentice

Since Specialization
Citations

This map shows the geographic impact of H. G. Prentice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. G. Prentice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. G. Prentice more than expected).

Fields of papers citing papers by H. G. Prentice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. G. Prentice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. G. Prentice. The network helps show where H. G. Prentice may publish in the future.

Co-authors

The 25 scholars most cited alongside H. G. Prentice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. G. Prentice Line = papers co-authored together H. G. Prentice links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS
The Lancet ·H. G. Prentice, George Janossy, L. Price-Jones, L K Trejdosiewicz, Dilip Panjwani, Stelios Graphakos, Kamal Ivory, Hilary Blacklock, M. J. M. L. Gilmore, N Tidman, D. Skeggs, Sarah E. Ball, J. Patterson, A. V. Hoffbrand
1984304
2
Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA
British Journal of Haematology ·Lorna M. Secker‐Walker, H. G. Prentice, Jill Durrant, S. Rchards, Emma Hall, G Harrison
1997199
3
Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation
Annals of Internal Medicine ·Hans‐Jochem Kolb, Gèrard Socié, Thomas Duell, M. T. Van Lint, André Tichelli, Jane F. Apperley, E. Nekolla, Per Ljungman, N Jacobsen, M. van Weel, R. Wick, Melanie Weiß, H. G. Prentice, (unknown)
1999195
4
USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA
The Lancet ·H. G. Prentice, George Janossy, D. Skeggs, Hilary Blacklock, K. F. Bradstock, Gideon Goldstein, A. V. Hoffbrand
1982185
5
IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS
The Lancet ·Jean‐Jacques Grob, H. G. Prentice, A. V. Hoffbrand, Teresa Tate, J. E. Grundy, Paul Griffiths, Melody Hughes, J. Z. Wimperis, Malcolm K. Brenner
1987183
6
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
British Journal of Haematology ·G.R. Morgenstern, A. G. Prentice, H. G. Prentice, Janet E. Ropner, Stephen Schey, David W. Warnock
1999180
7
Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-Versus-Host Disease and Graft Rejection
Blood ·G Hale, Mei‐Jie Zhang, Donald Bunjes, H. G. Prentice, David J. Spence, Mary M. Horowitz, A. John Barrett, Herman Waldmann
1998169
8
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
Bone Marrow Transplantation ·D. Gor, Caroline Sabin, H. G. Prentice, Nikki S. Vyas, Stephen Man, PD Griffiths, Vincent C. Emery
1998157
9
Progress in the Diagnosis and Management of Aspergillosis in Bone Marrow Transplantation: 13 Years' Experience
Clinical Infectious Diseases ·Paul McWhinney, C Kibbler, M. D. Hamon, Owen Smith, (unknown), L. A. Berger, R.K. Walesby, A. V. Hoffbrand, H. G. Prentice
1993152
10
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
British Journal of Haematology ·H. G. Prentice, C Kibbler, Archie Prentice
2000152
11
Impact of Previous Aspergillosis on the Outcome of Bone Marrow Transplantation
Clinical Infectious Diseases ·Fritz Offner, C Cordonnier, Per Ljungman, H. G. Prentice, Dan Engelhard, Dirk De Bacquer, F. Meunier, Ben de Pauw
1998152
12
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Blood ·Augustin Ferrant, Myriam Labopin, Francesco Frassoni, H. G. Prentice, J Cahn, Didier Blaise, Josy Reiffers, Giuseppe Visani, Miguel Á. Sanz, MA Boogaerts, Bob Löwenberg, NC Gorin
1997138
13
TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW
The Lancet ·J. Z. Wimperis, H. G. Prentice, Peter Karayiannis, Malcolm K. Brenner, Joyce E. Reittie, Paul Griffiths, A. V. Hoffbrand
1986135
14
Immunological analysis of the skin in graft versus host disease.
PubMed ·Irvin A. Lampert, George Janossy, Amanda Suitters, M Bofill, Sarah Palmer, E. C. Gordon‐Smith, H. G. Prentice, J. Alero Thomas
1982132
15
Second HLA-identical sibling transplants for leukemia recurrence.
PubMed ·(unknown), Mary M. Horowitz, K Atkinson, J. C. Biggs, Richard E. Champlin, Gerhard Ehninger, James Gajewski, Robert Peter Gale, RH Herzig, H. G. Prentice
1992130
16
Megakaryoblastic leukemia presenting as acute myelofibrosis -- a study of four cases with the platelet-peroxidase reaction
Blood ·BJ Bain, D Catovsky, Maureen M. O’Brien, H. G. Prentice, E. Lawlor, TO Kumaran, SR McCann, E Matutes, DA Galton
1981127
17
Management of Invasive Pulmonary Aspergillosis in Hematology Patients: A Review of 87 Consecutive Cases at a Single Institution
Clinical Infectious Diseases ·Tullie Yeghen, C C Kibbler, H. G. Prentice, L. A. Berger, R K Wallesby, Paul McWhinney, Fiona Lampe, Samuel W. Gillespie
2000125
18
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
British Journal of Haematology ·Mark W. Lowdell, R Craston, David Samuel, Marion Wood, Elena O’Neill, Vaskar Saha, H. G. Prentice
2002111
19
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy
Blood ·JE Reittie, David Gottlieb, HE Heslop, Olivier Leger, H. Drexler, G. R. Hazlehurst, A. V. Hoffbrand, H. G. Prentice, MK Brenner
1989110
20
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
PubMed ·Francesco Frassoni, Myriam Labopin, Éliane Gluckman, H. G. Prentice, J P Vernant, F. E. Zwaan, A Grañena, Gösta Gahrton, T.J.M. de Witte, Aloïs Gratwohl, Josy Reiffers, Norbert Claude Gorin
1996106

About H. G. Prentice

H. G. Prentice is a scholar working on Hematology, Immunology, Epidemiology, Oncology and Public Health, Environmental and Occupational Health, having authored 178 papers that have together received 7.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (87 papers), Immune Cell Function and Interaction (36 papers), Acute Myeloid Leukemia Research (33 papers), T-cell and B-cell Immunology (32 papers), Acute Lymphoblastic Leukemia research (25 papers), Immunotherapy and Immune Responses (22 papers), Cytomegalovirus and herpesvirus research (18 papers) and Chronic Myeloid Leukemia Treatments (13 papers). The work is most often cited by research in Hematology (3.9k citations), Immunology (2.3k citations), Genetics (872 citations), Transplantation (154 citations) and Infectious Diseases (1.1k citations). H. G. Prentice has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include A. V. Hoffbrand, Malcolm K. Brenner, George Janossy, Hilary Blacklock, J. Z. Wimperis, M. J. M. L. Gilmore, C Kibbler, Mark W. Lowdell, Paul Griffiths and David Gottlieb. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, The Lancet and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert C. HackmanBreakdown of academic impact, for papers by George E. SaleBreakdown of academic impact, for papers by Jan StorekBreakdown of academic impact, for papers by Rodrigo MartinoBreakdown of academic impact, for papers by Richard J. O’ReillyBreakdown of academic impact, for papers by Liisa VolinBreakdown of academic impact, for papers by Montserrat RoviraBreakdown of academic impact, for papers by Rafael F. DuarteBreakdown of academic impact, for papers by Jan J. CornelissenBreakdown of academic impact, for papers by Hisashi Sakamaki